BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 24183815)

  • 1. Druggable protein-protein interactions--from hot spots to hot segments.
    London N; Raveh B; Schueler-Furman O
    Curr Opin Chem Biol; 2013 Dec; 17(6):952-9. PubMed ID: 24183815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hot spot-based design of small-molecule inhibitors for protein-protein interactions.
    Guo W; Wisniewski JA; Ji H
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2546-54. PubMed ID: 24751445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural biology and drug discovery for protein-protein interactions.
    Jubb H; Higueruelo AP; Winter A; Blundell TL
    Trends Pharmacol Sci; 2012 May; 33(5):241-8. PubMed ID: 22503442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural conservation of druggable hot spots in protein-protein interfaces.
    Kozakov D; Hall DR; Chuang GY; Cencic R; Brenke R; Grove LE; Beglov D; Pelletier J; Whitty A; Vajda S
    Proc Natl Acad Sci U S A; 2011 Aug; 108(33):13528-33. PubMed ID: 21808046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-molecule protein-protein interaction inhibitors: therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations.
    Buchwald P
    IUBMB Life; 2010 Oct; 62(10):724-31. PubMed ID: 20979208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mining the characteristic interaction patterns on protein-protein binding interfaces.
    Li Y; Liu Z; Han L; Li C; Wang R
    J Chem Inf Model; 2013 Sep; 53(9):2437-47. PubMed ID: 23930922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are hot-spots occluded from water?
    Moreira IS; Ramos RM; Martins JM; Fernandes PA; Ramos MJ
    J Biomol Struct Dyn; 2014; 32(2):186-97. PubMed ID: 23384183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triathlon for energy functions: who is the winner for design of protein-protein interactions?
    Sharabi O; Dekel A; Shifman JM
    Proteins; 2011 May; 79(5):1487-98. PubMed ID: 21365678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A discriminative approach for identifying domain-domain interactions from protein-protein interactions.
    Zhao XM; Chen L; Aihara K
    Proteins; 2010 Apr; 78(5):1243-53. PubMed ID: 20027642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An integrative in silico approach for discovering candidates for drug-targetable protein-protein interactions in interactome data.
    Sugaya N; Ikeda K; Tashiro T; Takeda S; Otomo J; Ishida Y; Shiratori A; Toyoda A; Noguchi H; Takeda T; Kuhara S; Sakaki Y; Iwayanagi T
    BMC Pharmacol; 2007 Aug; 7():10. PubMed ID: 17705877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of hot region organization in hub proteins.
    Cukuroglu E; Gursoy A; Keskin O
    Ann Biomed Eng; 2010 Jun; 38(6):2068-78. PubMed ID: 20437205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Computational Investigation of Small-Molecule Engagement of Hot Spots at Protein-Protein Interaction Interfaces.
    Xu D; Si Y; Meroueh SO
    J Chem Inf Model; 2017 Sep; 57(9):2250-2272. PubMed ID: 28766941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using peptides to study protein-protein interactions.
    Benyamini H; Friedler A
    Future Med Chem; 2010 Jun; 2(6):989-1003. PubMed ID: 21426115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical and structural lessons from recent successes in protein-protein interaction inhibition (2P2I).
    Morelli X; Bourgeas R; Roche P
    Curr Opin Chem Biol; 2011 Aug; 15(4):475-81. PubMed ID: 21684802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of computational hot spots in protein interfaces: combining solvent accessibility and inter-residue potentials improves the accuracy.
    Tuncbag N; Gursoy A; Keskin O
    Bioinformatics; 2009 Jun; 25(12):1513-20. PubMed ID: 19357097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding protein-protein interactions using local structural features.
    Planas-Iglesias J; Bonet J; García-García J; Marín-López MA; Feliu E; Oliva B
    J Mol Biol; 2013 Apr; 425(7):1210-24. PubMed ID: 23353828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AlphaSpace: Fragment-Centric Topographical Mapping To Target Protein-Protein Interaction Interfaces.
    Rooklin D; Wang C; Katigbak J; Arora PS; Zhang Y
    J Chem Inf Model; 2015 Aug; 55(8):1585-99. PubMed ID: 26225450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
    Thiel P; Kaiser M; Ottmann C
    Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragment-based drug discovery supports drugging 'undruggable' protein-protein interactions.
    Wang ZZ; Shi XX; Huang GY; Hao GF; Yang GF
    Trends Biochem Sci; 2023 Jun; 48(6):539-552. PubMed ID: 36841635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting druggable binding sites at the protein-protein interface.
    Fuller JC; Burgoyne NJ; Jackson RM
    Drug Discov Today; 2009 Feb; 14(3-4):155-61. PubMed ID: 19041415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.